Fresenius Kabi has opened two new antibiotic production lines in Portugal, creating 80 new jobs and investing €17 million. The expansion is a commitment to providing high-quality drugs and supporting the Santiago de Besteiros facility. The plant also produces other pharmaceuticals and has around 600 employees.
Fresenius Kabi has put two new production lines for antibiotics into operation at its plant in Santiago de Besteiros, Portugal.
A new 6,000-square-meter (almost 65,000-square-foot) building was erected to house the two lines, which will be used to produce penicillin for intravenous administration. About 80 new jobs are being created at the Santiago de Besteiros plant by the expansion. The total investment is about €17 million.
Dr. Michael Schönhofen, member of the Fresenius Kabi Management Board and President of the Pharmaceuticals Division, said: “This expansion is a clear commitment to our Santiago de Besteiros facility, and to Portugal. It is also a part of fulfilling our promise to provide patients worldwide with high-quality drugs.”
The Fresenius Kabi plant in Santiago de Besteiros manufactures various pharmaceuticals, such as antibiotics and infusion solutions. As one of Portugal’s largest pharmaceutical production sites, it has about 600 employees.